Arkolith/Insider Trading/CDTX/Form 4

Davarpanah Nicole Negar

Chief Medical OfficerCidara Therapeutics, Inc. (CDTX) · full profile →Form 4 · filed Jan 7, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
2 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Disposed to issuer(D)13K$221.50$2.8M8K
Jan 7, 2026Disposed to issuer(D)8K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 7, 2026Disposed to issuer(D)20K——0
Jan 7, 2026Disposed to issuer(D)30K——0
Jan 7, 2026Disposed to issuer(D)63K——0
Jan 7, 2026Disposed to issuer(D)11K——0
Jan 7, 2026Disposed to issuer(D)5K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002067554-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML